[
  {
    "ts": null,
    "headline": "Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity",
    "summary": "Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find out why I rate ZTS stock a Buy.",
    "url": "https://finnhub.io/api/news?id=d39ad6ddb47070a82ec49974aba28e04ffeff4bfbf310f5a037685e771319623",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739464995,
      "headline": "Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity",
      "id": 132708868,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1642526830/image_1642526830.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find out why I rate ZTS stock a Buy.",
      "url": "https://finnhub.io/api/news?id=d39ad6ddb47070a82ec49974aba28e04ffeff4bfbf310f5a037685e771319623"
    }
  },
  {
    "ts": null,
    "headline": "Robert F. Kennedy Jr. Is Confirmed as Top U.S. Health Official",
    "summary": "Robert F. Kennedy Jr. Is Confirmed as Top U.S. Health Official",
    "url": "https://finnhub.io/api/news?id=cfb774a00cba660d467df22a656f09be05b7b0a14f270f64931c217ae51eb7f1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739447460,
      "headline": "Robert F. Kennedy Jr. Is Confirmed as Top U.S. Health Official",
      "id": 132704586,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Robert F. Kennedy Jr. Is Confirmed as Top U.S. Health Official",
      "url": "https://finnhub.io/api/news?id=cfb774a00cba660d467df22a656f09be05b7b0a14f270f64931c217ae51eb7f1"
    }
  }
]